Page last updated: 2024-08-24

lisofylline and B-Cell Chronic Lymphocytic Leukemia

lisofylline has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldari, CT; Capitani, N; Cattaneo, F; D'Elios, MM; Frezzato, F; Patrussi, L; Semenzato, G; Trentin, L1

Other Studies

1 other study(ies) available for lisofylline and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.
    Oncotarget, 2016, Aug-30, Volume: 7, Issue:35

    Topics: Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Interleukin-12; Leukemia, Lymphocytic, Chronic, B-Cell; Pentoxifylline; Phosphorylation; Promoter Regions, Genetic; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; STAT4 Transcription Factor; Tumor Microenvironment

2016